MedicarePartD.guide

A non-government resource built from CMS public data

SGLT2 inhibitors on every 2026 Arkansas Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Arkansas cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

SGLT2 inhibitors by 2026 Arkansas Part D plan
DrugWellcare Classic$0.00/moS4802-073Wellcare Value Script$0.00/moS4802-153HealthSpring Assurance Rx$0.00/moS5617-225Humana Basic Rx Plan$0.00/moS5884-141Humana Value Rx Plan$0.00/moS5884-198BlueMedicare Value Rx$52.50/moS5795-003HealthSpring Extra Rx$54.50/moS5617-369AARP Medicare Rx Saver from UHC$65.10/moS5921-364SilverScript Choice$73.50/moS5601-038Humana Premier Rx Plan$92.40/moS5884-165AARP Medicare Rx Preferred from UHC$114.90/moS5921-400BlueMedicare Premier Rx$181.20/moS5795-002
JardianceempagliflozinTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 319%QL 30/30dTier 317%QL 30/30dTier 318%QL 30/30dTier 318%QL 30/30dTier 3$45.00QL 30/30dTier 316%QL 30/30dTier 320%QL 30/30d
FarxigadapagliflozinNot coveredNot coveredTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 319%QL 30/30dTier 317%QL 30/30dNot coveredTier 318%QL 30/30dTier 3$45.00QL 30/30dNot coveredTier 320%QL 30/30d
dapagliflozingeneric FarxigaTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 325%QL 30/30dTier 320%QL 30/30dTier 2$5.00QL 30/30dTier 317%QL 30/30dTier 318%QL 30/30dTier 318%QL 30/30dTier 3$45.00QL 30/30dTier 316%QL 30/30dTier 1$0.00QL 30/30d
InvokanacanagliflozinTier 426%QL 60/30dTier 440%QL 60/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
SteglatroertugliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
InpefasotagliflozinNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.